上下游产品
CAS号50868-72-9 5-甲氧基-2-甲基苯胺 | CAS号452-78-8 3-氟-4-甲基苯酚 | CAS号77-78-1 硫酸二甲酯 | CAS号1427-07-2 2-氟-4-硝基甲苯 | CAS号452-77-7 3-氟-4-甲基苯胺 | CAS号104-93-8 4-甲基苯甲醚(MSO) | CAS号394-42-3 2-氟-4-甲氧基苯甲酸 | CAS号331746-01-1 3-fluoro-4-meth... | CAS号452-78-8 3-氟-4-甲基苯酚 | CAS号7656-31-7 2-氨基-3-(2-氟-4-羟... | CAS号54788-19-1 2-氟-4-甲氧基苄溴合成工艺路线路线简述
- 合成目标产物 3-Fluoro-4-Methylanisole 主要起始原料 3-Fluoro-4-Methylphenol And Iodomethane
- (文献来源)合成步骤主要原料 3-Fluoro-4-Methylphenol 和 Iodomethane
3-氟-4-甲基苯胺置于sodium Hydroxide,硫酸,硫酸二甲酯,Sodium Nitrite体系中,化学反应生成 3-氟-4-甲基苯甲醚
参考文献:The Synthesis Of 2-Fluoro-Dl-Tyrosine And 2-Fluoro-4-Methoxy-Dl-Phenylalanine
标题:The Synthesis Of 2-Fluoro-Dl-Tyrosine And 2-Fluoro-4-Methoxy-Dl-Phenylalanine
摘要:
DOI:10.1021/ja01160A113
海关参考信息
- 2902300000-甲苯
2905110000-甲醇
2908199090-其他酚的卤化衍生物
2908999090-其他酚的硝化衍生物 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-8106031-B2
优先权日:2006-05-02
标题:Hydrolytically-resistant boron-containing therapeutics and methods of use
发明人:LEE VING; PLATTNER JACOB J; BENKOVIC STEPHEN J; BAKER STEPHEN J; MAPLES KIRK R; BELLINGER-KAWAHARA CAROLYN; AKAMA TSUTOMU; ZHANG YONG-KANG; SINGH RAJESHWAR; SAURO VITTORIO A
权利人:LEE VING; PLATTNER JACOB J; BENKOVIC STEPHEN J; BAKER STEPHEN J; MAPLES KIRK R; BELLINGER-KAWAHARA CAROLYN; AKAMA TSUTOMU; ZHANG YONG-KANG; SINGH RAJESHWAR; SAURO VITTORIO A; ANACOR PHARMACEUTICALS INC
摘要:Compositions and methods of use of boron derivatives, including benzoxaboroles, benzazaboroles and benzthiaboroles, as therapeutic agents for treatment of diseases caused by fungi, yeast, bacteria or viruses are disclosed, as well as methods for synthesis of said agents and compositions thereof.
专利号:US-10233182-B2
优先权日:2014-04-04
标题 :Substituted spirocyclic inhibitors of autotaxin
发明人:BABISS LEE; CLARK MATTHEW; KEEFE ANTHONY D; MULVIHILL MARK J; NI HAIHONG; RENZETTI LOUIS; RUEBSAM FRANK; WANG CE; XIE ZHIFENG; ZHANG YING
权利人:X RX INC
摘要:The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.
专利号:WO-2009081259-A1
优先权日:2007-12-21
标题 :Phenoxy-pyridyl derivatives
发明人:BARTA NANCY SUE; CAMPBELL BRIAN MICHAEL; DOUNAY AMY BETH; GRAY DAVID LAWRENCE FIRMAN; ZORN STEVIN HOWARD
权利人:PFIZER; BARTA NANCY SUE; CAMPBELL BRIAN MICHAEL; DOUNAY AMY BETH; GRAY DAVID LAWRENCE FIRMAN; ZORN STEVIN HOWARD
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I), as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
专利号:US-2008269233-A1
优先权日:2005-08-04
标 题:Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
发明人:ANDREWS MARK DAVID; BROWN ALAN DANIEL; SEBASTIEN DAVID; LANSDELL MARK IAN
权利人:ANDREWS MARK DAVID; BROWN ALAN DANIEL; SEBASTIEN DAVID; LANSDELL MARK IAN
摘要:The present invention relates to a class of compounds of general formula (I) n n n n n n n n n n and the salts, hydrates, solvates, polymorphs and prodrugs wherein n, R 6 , R 7 and R 10 are as defined herein and especially to MCR4 agonist compounds of formula (I), to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.
专利号:US-9233981-B1
优先权日:2013-02-15
标题:Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
发明人:BRODNEY MICHAEL AARON; O'NEILL BRIAN THOMAS; BUTLER CHRISTOPHER RYAN; BECK ELIZABETH MARY
权利人:PFIZER
摘要:The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, n nwherein the variables R 1 and R 2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.